Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats

Journal of International Medical Research

Volumn 33, Issue 2, 2005, Pages 196-206

  Akgun, E ^a   Caliskan C ^a   Celik, H A ^a   Ozutemiz, A O ^a   Tuncyurek, M ^a   Aydin, H H ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidant; Experimental colitis; N acetylcysteine; Oxidative stress; Rat

Indexed keywords

ACETIC ACID; ACETYLCYSTEINE; FREE RADICAL; GLUTATHIONE; MYELOPEROXIDASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOASSAY; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTECTION; PROTEIN LOCALIZATION; RAT; SCORING SYSTEM; TISSUE DISTRIBUTION;

EID: 14944378529     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300207     Document Type: Article

References (20)

1. Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP: Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 2001; 15: 731-748.
2. Goh J, O'Morain CA: Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 2003; 17: 307-320.
3. Hart A, Kamm MA: Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther 2002; 16: 2017-2028.
4. Kruidenier L, Verspaget HW: Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment Pharmacol Ther 2002; 16: 1997-2015.
5. Reichenberger F, Tamm M: N-acetylcysteine in the therapy of chronic bronchitis. Pneumologie 2002; 56: 793-797.
6. Higa A, Eto T, Nawa Y: Evaluation of the role of neutrophils in the pathogenesis of acetic acid-induced colitis in mice. Scand J Gastroenterol 1997; 32: 564-568.
7. Fedorak RN, Empey LR, Walker K: Verapamil alters eicosanoid synthesis and accelerates healing during experimental colitis in rats. Gastroenterology 1992; 102: 1229-1235.
8. Krawisz, JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350.
9. Rutgeerts P, Van Deventer S, Schreiber S: Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition. Aliment Pharmacol Ther 2003; 17: 1435-1450.
10. Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C: Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 1447-1452.
11. Ajuebor MN, Swain MG: Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 2002; 105: 137-143.
12. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38: 216-222.
13. Hommes DW, Meenan J, Dijkhuizen S, Ten Kate FJ, Tytgat GN, Van Deventer SJ: Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis. Clin Exp Immunol 1996; 106: 529-533.
14. Loguercio C, D'Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, et al: Glutathione supplementation improves oxidative damage in experimental colitis. Dig Liver Dis 2003; 35: 635-641.
15. Chaudiere J, Ferrari-Iliou R: Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 1999; 37: 949-962.
16. Bock KW, Lipp HP, Bock-Hennig BS: Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica 1990; 20: 1101-1111.
17. Kobayashi T, Robinson MK, Robinson V, DeRosa E, Wilmore DW, Jacobs DO: Glutathione depletion alters hepatocellular high-energy phosphate metabolism. J Surg Res 1993; 54: 189-195.
18. Ravindranath V, Reed DJ: Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress. Biochem Biophys Res Commun 1990; 169: 1075-1079.
19. Wallace JL: Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease. Dig Liver Dis 2003; 35 (Suppl 2): S35-S40.
20. Kankuri E, Asmawi MZ, Korpela R, Vapaatalo H, Moilanen E: Induction of iNOS in a rat model of acute colitis. Inflammation 1999; 23: 141-152.